Tyrosine phosphorylation of ␤ 3 integrins is a permissive stage in the activation of ␣ IIb ␤ 3 and ␣ v ␤ 3 in platelets and leukocytes, respectively. In this study we demonstrated direct phosphorylation of ␤ 3 integrins as a result of interaction with soluble monomeric ligand, and we characterized the differential kinetics of ␤ 3 phosphorylation as a consequence of ␣ subunit pairing. We found that ␤ 3 phosphorylation is initiated by RGD peptide binding in a dose-dependent and saturable fashion with ␣ IIb ␤ 3 becoming phosphorylated and dephosphorylated more rapidly than ␣ v ␤ 3 . Site mapping of phosphate incorporation reveals significant phosphorylation at Tyr-747 in both ␤ 3 integrin species with incorporation at Tyr-759 found at significant levels only in ␣ IIb ␤ 3 . Mutation of cytoplasmic ␤ 3 tyrosine residues in a transfection model prevents cell adhesion via these integrins. These data demonstrate that recognition of ligand is sufficient to induce ␤ 3 tyrosine phosphorylation and suggests that this event is regulated by the ␣ subunit pairing of ␤ 3 .
Tyrosine phosphorylation of ␤ 3 integrins is a permissive stage in the activation of ␣ IIb ␤ 3 and ␣ v ␤ 3 in platelets and leukocytes, respectively. In this study we demonstrated direct phosphorylation of ␤ 3 integrins as a result of interaction with soluble monomeric ligand, and we characterized the differential kinetics of ␤ 3 phosphorylation as a consequence of ␣ subunit pairing. We found that ␤ 3 phosphorylation is initiated by RGD peptide binding in a dose-dependent and saturable fashion with ␣ IIb ␤ 3 becoming phosphorylated and dephosphorylated more rapidly than ␣ v ␤ 3 . Site mapping of phosphate incorporation reveals significant phosphorylation at Tyr-747 in both ␤ 3 integrin species with incorporation at Tyr-759 found at significant levels only in ␣ IIb ␤ 3 . Mutation of cytoplasmic ␤ 3 tyrosine residues in a transfection model prevents cell adhesion via these integrins. These data demonstrate that recognition of ligand is sufficient to induce ␤ 3 tyrosine phosphorylation and suggests that this event is regulated by the ␣ subunit pairing of ␤ 3 .
The ␤ 3 integrin subunit has been shown to become tyrosinephosphorylated either as ␣ v ␤ 3 or as ␣ IIb ␤ 3 in monocytes, endothelial cells, platelets, and some cell lines (1) (2) (3) . Mutation of Tyr-747 of the ␤ 3 cytoplasmic tail in ␣ v ␤ 3 -transfected hematopoietic cell models prevents their agonist-dependent adhesion, whereas the constitutive adhesion of nonhematopoietic cells that bear these mutant integrins proceeds unaffected (2) . The apparent hematopoietic-specific requirement for integrity of the ␤ 3 cytoplasmic tyrosines is also reflected in a murine model that bears a genetic mutation of the ␤ 3 cytoplasmic tyrosine residues in which the identifiable phenotype is a disorder in platelet clot strength, an ␣ IIb ␤ 3 -dependent function (4) .
In an ␣ v ␤ 3 -transfected hematopoietic cell model, mutation of Tyr-747 of ␤ 3 is sufficient to eliminate ␤ 3 phosphorylation and ␣ v ␤ 3 -mediated adhesion to vitronectin substrate in a static adhesion model. Neither an individual Tyr-759 point mutation nor a combined double-point mutation suggests a role for Tyr-759 in ␣ v ␤ 3 -dependent adhesion (2) . Subsequently, a sensitive spinningdisc assay of adhesion force has suggested an additive role for both Tyr-747 and Tyr-759 in adhesion; however, the effects of Tyr-747 mutation were clearly dominant (5). Because both tyrosines reside in NXXY motifs, potential exists for the assembly of two similar signaling complexes. In the murine model, the effect of single-point mutations has not yet been assessed. Likewise, the individual requirement for either Tyr-747 or has not yet been determined for ␤ 3 when coupled with ␣ IIb .
How ␤ 3 becomes tyrosine-phosphorylated is not yet understood. Our initial observation of this biochemical modification occurred in the presence of exogenous Mn 2ϩ Cl 2 (1) . Because the presence of divalent cations has been shown to modify the conformation of ␤ 3 integrins, it was initially suspected that ␤ 3 tyrosine phosphorylation may be involved in affinity regulation of integrins that is reflected in the conformational change. However, this theory has been disproved (2) . Additionally, we have demonstrated that ␤ 3 becomes tyrosine-phosphorylated on ␣ v ␤ 3 attachment to a specific ligand such as vitronectin or anti-␤ 3 mAb 1 (2) . Observations in platelets have failed to demonstrate ␤ 3 tyrosine phosphorylation in the absence of platelet aggregation (6) . Although aggregation and adhesion both involve integrin receptor clustering, we know of no evidence to indicate that Mn 2ϩ Cl 2 should do so. We report that ␤ 3 integrin interaction with soluble monomeric hexapeptide that contains the adhesive tripeptide ArgGly-Asp (RGD) is sufficient to induce phosphorylation of ␤ 3 at Tyr-747 in ␣ v ␤ 3 and at both Tyr-747 and Tyr-759 in ␣ IIb ␤ 3 . Further, RGD-induced phosphorylation of ␤ 3 is dose-dependent and regulated by the ␣ subunit partner of ␤ 3 . Unlike ␣ v ␤ 3 , mutation of either Tyr-747 or Tyr-759 of ␤ 3 in ␣ IIb ␤ 3 resulted in a partial reduction in cell adhesion to fibrinogen. Simultaneous mutation of both Tyr-747 and Tyr-759 as seen in ␣ v ␤ 3 completely inhibited agonist-dependent adhesion via ␣ IIb ␤ 3 . Incorporation of phosphate into ␤ 3 in transfected cell models was similar to that seen in both murine and human primary macrophages and occurred in approximately half of the recovered ␤ 3 in RGD-stimulated suspended cells. The effects of these ␤ 3 mutations on adhesions both in vitro and in vivo combined with significant phosphorylation stoichiometry suggests that tyrosine phosphorylation of ␤ 3 is a prominent event in hematopoietic cell adhesion via ␤ 3 integrins.
EXPERIMENTAL PROCEDURES
Transfections, Cells, and Flow Cytometry-K562 cells were stably transfected with cDNA that encoded human integrin subunits ␣ v or ␣ IIb with either ␤ 3 wild-type or ␤ 3 in which tyrosine residues at position 747, 759, or both, were mutated to phenylalanine as described previously (2) . Equivalently high ␤ 3 -expressing cell populations were obtained by cell sorting with use of mAb AP3 against ␤ 3, and expression is reported as the mean channel fluorescence in Table I for ␤ 3 as well as for ␣ v or ␣ IIb subunits. Human peripheral blood monocyte-derived macrophages and murine bone marrow-derived macrophages were prepared as described previously (2) .
␤ 3 Phosphorylation-For visual analysis of ␤ 3 tyrosine phosphorylation, 1 ϫ 10 7 K562 cells that expressed ␤ 3 integrins were suspended in Iscove's modifed Dulbecco's medium that contained 75 M NaVO 4 and incubated with or without the indicated concentrations of Gly-Arg-GlyAsp-Ser-Pro (GRGDSP) peptide at room temperature for the indicated times. After incubation, cells were separated from the medium by centrifugation and lysed in radioimmune precipitation assay buffer. Immunoprecipitation of ␤ 3 and Western blotting for phosphotyrosine was performed as previously described and visualized by using ECL chemistry. 10% of ␤ 3 immunoprecipitates were analyzed in parallel for ␤ 3 recovery by direct Western blotting using mAb 7G2 against ␤ 3 . For GRGDSP peptide dose dependence studies, cells were stimulated with indicated doses of peptide for 15 min. For time course studies, cells were incubated with 2.0 mM GRGDSP for 180 min with gentle rocking. Aliquots were removed for immunoprecipitation at the indicated times and processed as described previously. For quantitation of ␤ 3 tyrosine phosphorylation, Western blots were processed by using ECL-Plus chemistry, exposed to collection screens, analyzed with a Molecular Devices phosphorimaging device, normalized to total ␤ 3 recovered, and reported as arbitrary fluorescent units.
To determine the site and stoichiometry of ␤ 3 tyrosine phosphorylation, ␤ 3 was immunoprecipitated from human monocyte-derived macrophages, murine bone marrow-derived macrophages, and K562 cells that expressed either ␣ v ␤ 3 or ␣ IIb ␤ 3 . After [
32 P]-orthophosphate loading of cells, GRGDSP peptide was added to 2.0 mM concentration and cells were suspended in Iscove's modifed Dulbecco's medium for 20 min at room temperature. The ␤ 3 subunit was immunoprecipitated with polyclonal antibody directed against the ␤ 3 cytoplasmic tail (BIO-SOURCE) covalently linked to Sepharose via dimethyl pimelimidate according to the manufacturer's instructions. ␤ 3 was released from Sepharose by using 0.1 M glycine, 0.01 M NaPO 4 , 0.45 M NaCl, pH 3.5, and subjected to limited proteolysis with ␥-thermolysin M2 (gift of Hiroshi Takayana, Tokyo University) for 2.5 min. Digested protein was subjected to isoelectric focusing (pI 4.5-6.5) to remove IgG contaminants followed by a second dimension of 18% SDS-PAGE tube gel. Electroeluted peptides were monitored for 32 P incorporation by ␤-scintillation, and the smallest radioactive peptides were analyzed by pico-tag analysis for amino acid concentration and both Nterminal Edman degradation and C-terminal sequencing to determine the peptide sequence and the site of 32 P incorporation. For all samples, the sequenced peptide began at residue 741 of the ␤ 3 cytoplasmic tail as predicted for ␥-thermolysin M2. The presence of phosphotyrosine was determined by the shift to the anilinothiazoline derivative. Pico-tag amino acid quantitation combined with reference date-corrected 32 P scintigraphy permitted calculation of a molecular phosphorylation stoichiometry from the moles of ␤ 3 residues 741-760 per mol of 32 P, which indicates the percentage of ␤ 3 molecules phosphorylated.
Adhesion Assays-For adhesion to extracellular matrix ligand, 96-well plates (Immulon-II, Dynatech, Chantilly, VA) were coated overnight with either 1.0 g/ml vitronectin or 10 g/ml fibrinogen in phosphate-buffered saline at 4°C followed by washing and blocking with 0.5% casein in phosphate-buffered saline for 30 min at room temperature (2). 1 ϫ 10 5 K562 cells that expressed wild-type or Tyr-Phe mutant ␤ 3 integrins were fluorescently labeled with calcein-AM as described and placed in each well in Iscove's modified Dulbecco's medium without serum and with or without phorbol 12-myristate 13-acetate (20 ng/ml). After 1 h of incubation at 37°C, the fluorescence of each well was determined before and after three washes with phosphate-buffered saline to calculate the percentage of cells that adhered. Shown is the average Ϯ S.D. of no fewer than five determinations performed in triplicate for each group.
RESULTS
To determine the role of Tyr-747 and Tyr-759 of the ␤ 3 cytoplasmic tail in ␤ 3 tyrosine phosphorylation and ␤ 3 -mediated adhesion, a stable transfection model in K562 cells was constructed, in which equivalent expression levels between each population were attained (Table I) (2) . K␣ v ␤ 3 was incubated with increasing concentrations of GRGDSP peptide, and samples were evaluated for ␤ 3 tyrosine phosphorylation as described under "Experimental Procedures" (Fig. 1) . ␤ 3 phosphorylation was increased in a dosedependent fashion by GRGDSP and reached maximum detected levels at 2.0 mM GRGDSP during a 15-min incubation. The addition of GRGESP peptides at concentrations as high as 5 mM failed to induce ␤ 3 tyrosine phosphorylation in K␣ v ␤ 3 (data not shown). Incubation of K␣ IIb ␤ 3 with increasing concentrations of GRGDSP also demonstrated maximum ␤ 3 tyrosine phosphorylation at 2.0 mM GRGDSP (data not shown).
Because we had previously demonstrated conditions under which the ␤ 3 subunit of ␣ v ␤ 3 but not ␣ IIb ␤ 3 could become tyrosine-phosphorylated, we hypothesized that ␣ subunit pairing elicited differential regulatory events (1). Because dose dependence of a common ligand failed to reveal differences in ␤ 3 phosphorylation between the two ␤ 3 integrins, we evaluated the phosphorylation of these receptors after peptide ligand binding over an extensive time course as described under ''Experimental Procedures'' (Fig. 2) . After the removal of a time zero sample, addition of 2.0 mM GRGDSP induced an increase in ␤ 3 phosphorylation in both ␣ IIb ␤ 3 and ␣ v ␤ 3. However, GRGDSP-induced phosphorylation in ␤ 3 occurred more rapidly in ␣ IIb ␤ 3 than in ␣ v ␤ 3. Further, the phosphorylation of ␤ 3 in ␣ IIb ␤ 3 peaked at 15 min and began to decrease even in the continued presence of the ligand and reached baseline levels after 30 min. In contrast, the phosphorylation of ␤ 3 in ␣ v ␤ 3 was maintained as long as 1 h after the removal of the ligand. We have previously demonstrated that mutation of Tyr-747 of ␤ 3 in ␣ v ␤ 3 was sufficient to eliminate ␤ 3 phosphorylation induced either by Mn 2ϩ or adhesion to specific ligand (2). Mutation of Tyr-759 of ␤ 3 had no effect on ␤ 3 phosphorylation; however, a sensitive adhesion force measure suggested that the integrity of this residue contributes to ␣ v ␤ 3 -mediated adhesion (5) . In ␣ IIb ␤ 3 it is unknown which tyrosine residues are required for ␤ 3 phosphorylation either in vivo or in vitro. In a murine genomic model, simultaneous mutation of Tyr-747 and Tyr-759 elicited an ␣ IIb ␤ 3 -dependent phenotype (4). To determine the relative contribution of these tyrosines to ␤ 3 phosphorylation in ␣ IIb ␤ 3 , we assayed ␤ 3 phosphorylation induced by GRGDSP peptide in ␣ IIb ␤ 3 mutants bearing phenylalanine substitutions at Tyr-747 and Tyr-759 both individually and concurrently. In contrast to ␣ v ␤ 3 , mutation of ␤ 3 Tyr-747 of ␣ IIb ␤ 3 resulted in an only partial reduction in ␤ 3 phosphorylation. This suggests that phosphorylation occurred both at Tyr-747 and at other sites. Mutation of ␤ 3 Tyr-759 in ␣ IIb ␤ 3 did not appear to reduce GRGDSP-induced ␤ 3 phosphorylation and as seen in ␣ v ␤ 3 , concurrent mutation of both Tyr-747 and Tyr-759 resulted in a complete loss of ␤ 3 phosphorylation. These results further support the hypothesis that the ␣ subunit pairing of ␤ 3 elicits differential regulatory mechanisms for ␤ 3 phosphorylation induced by ligand binding.
To definitively identify the sites of phosphate incorporation in the ␤ 3 cytoplasmic tail, a protocol was developed whereby a small peptide domain that encompassed both Tyr-747 and Tyr-759 of the ␤ 3 tail could be purified after ligand-induced receptor phosphorylation and immunorecovery. Radiostoichiometry, amino acid quantitation, and direct sequencing were used as described under ''Experimental Procedures'' to determine the molecular stoichiometry of ␤ 3 tyrosine phosphorylation (Table  II) . As suggested by Western blot experimentation, significant phosphate incorporation into the ␤ 3 subunit of ␣ v ␤ 3 occurred only at Tyr-747. Under the described experimental conditions, similar levels of phosphate incorporation at Tyr-747 were seen in ␣ v ␤ 3 recovered from our model cell line K␣ v ␤ 3, human monocyte-derived macrophages, and murine bone-marrow-derived macrophages. Unable to purify sufficient quantities of ␣ IIb ␤ 3 from platelets, we assessed phosphate incorporation into ␤ 3 in our model cell line K␣ IIb ␤ 3 . Interestingly, significant phosphorylation occurred at both Tyr-747 and Tyr-759 in ␤ 3 recovered from these cells. This result is in agreement with our Western blot analyses (Fig. 3 ) in which mutation of either individual tyrosine failed to completely block ␤ 3 phosphorylation and suggests that although Tyr-747 is the primary site of phosphate incorporation into ␤ 3 in both ␣ IIb ␤ 3 and ␣ v ␤ 3 , phosphorylation of Tyr-759 does occur in ␣ IIb ␤ 3 .
Both phosphomapping studies and Western blot analysis of tyrosine mutant ␤ 3 suggested that both tyrosine residues of ␤ 3 contribute to ␣ IIb ␤ 3 function. Because this is in contrast to our previous studies of ␣ v ␤ 3 behavior, we directly compared the adhesive capabilities of ␣ IIb ␤ 3 and ␣ v ␤ 3 with their preferred ligands (fibrinogen and vitronectin, respectively) and the dependence of these adhesions on the ␤ 3 cytoplasmic tail tyrosine residues (Fig. 4) . As with K␣ v ␤ 3 attachment to vitronectin, K␣ IIb ␤ 3 adhesion to fibrinogen required phorbol 12-myristate 13-acetate-induced activation of protein kinase C and was completely inhibited by anti-␤ 3 mAb 1A2 (data not shown). Similar to ␣ v ␤ 3, mutation of ␤ 3 Tyr-747 in ␣ IIb ␤ 3 reduced K␣ IIb ␤ 3 adhesion to fibrinogen. However, in contrast were incubated with 2.0 mM GRGDSP peptide as described under ''Experimental Procedures.'' Peptide was added immediately after the zero time point sampling, and peptide was removed by brief centrifugation and buffer change immediately before the 60-min time point sampling. Equal aliquots were removed at the indicated time points for analysis of ␤ 3 tyrosine phosphorylation as described for Fig. 1 . Data are presented as arbitrary fluorescence units, and the mean Ϯ S.E. from three experiments is shown. P-Loaded K562 cells stably expressing either ␣ IIb ␤ 3 or ␣ v ␤ 3 , human monocyte-derived macrophages (hMDM), and murine bone marrowderived macrophages (mBMM) were treated to permit ␤ 3 tyrosine phosphorylation and processed as described under "Experimental Procedures." Data are presented as the percent of tyrosines at positions 747 and 759 that incorporated phosphate. Shown is mean Ϯ S.E. from the indicated number of determinations (n).
Tyr-747
Tyr-759 (n) 2) to ␣ v ␤ 3 , mutation of Tyr-759 also resulted in a significant yet incomplete reduction in adhesion. Finally, concurrent mutation of both ␤ 3 cytoplasmic tyrosines in both ␣ v ␤ 3 and ␣ IIb ␤ 3 completely inhibited adhesion to specific ligand. The results of these functional studies support the hypothesis that ␣ subunit pairing elicits differential regulatory mechanisms for ␤ 3 phosphorylation and suggest that these two closely related integrins use this modification in slightly different ways to achieve firm adhesion.
DISCUSSION
As evidenced by both in vitro and in vivo models, tyrosine phosphorylation of ␤ 3 integrins is an important permissive step in the adhesive process of hematopoietic cell types (1) (2) (3) (4) . Genetic mutation of ␤ 3 cytoplasmic tyrosines demonstrates a requirement for phosphorylation for firm adhesion both in vitro and in vivo (2, 4) The ␤ 3 cytoplasmic tail contains two tyrosine residues, both within NXXY sequences, a common motif for the assembly of signaling complexes (7) . For ␣ v ␤ 3 we have previously demonstrated that the membrane proximal tyrosine, Tyr-747, is solely required for ␤ 3 phosphorylation (2). Further, mutation of Tyr-747 completely prevents adhesion in a hematopoietic cell model. In ␣ IIb ␤ 3 functional evidence for the role of ␤ 3 tyrosine phosphorylation comes from a genetically modified mouse in which both ␤ 3 cytoplasmic tyrosine residues were mutated to phenylalanine, resulting in an animal with deficiencies in platelet clot strength (4). To focus future mechanistic studies of this signaling event, we have identified the minimum stimulus required for ␤ 3 phosphorylation and mapped the phosphorylation sites in ␤ 3 when partnered with either ␣ v or ␣ IIb.
It has been known for some time that ␤ 3 integrin binding of small peptide ligands is sufficient to induce a conformational change in the integrin (8) . Previous reports have demonstrated ␤ 3 tyrosine phosphorylation resulting from adhesion to ligand or antibody, platelet aggregation, and addition of exogenous Mn 2ϩ (2, 3) . We now report that ␤ 3 solution binding of monomeric RGD peptide, at concentrations equivalent to those which induce integrin conformational change, are sufficient to induce phosphorylation of ␤ 3 cytoplasmic tyrosine residues. RGD-induced phosphorylation in the absence of receptor aggregation, cell spreading, or cell adhesion suggests that this modification of ␤ 3 occurs very early during integrin-mediated events, and supports our hypothesis that phosphorylated ␤ 3 is the required substrate for signals that promote hematopoietic cell adhesion such as protein kinase C.
Our initial observations failed to detect ␤ 3 phosphorylation when partnered with ␣ IIb in K562 cells. In subsequent reports we have demonstrated ␤ 3 phosphorylation in platelets, presumably from ␣ IIb ␤ 3 , and this finding has been confirmed in other laboratories (3) . To determine whether our initial inability to visualize ␤ 3 phosphorylation in ␣ IIb ␤ 3 was caused by ␣ subunit regulation, we directly compared both the time and dose responses of the two ␤ 3 integrins with peptide ligand-induced tyrosine phosphorylation. Although model cell systems may not completely reflect ␤ 3 phosphorylation in a primary cell type, the analysis of both integrins within a homologous system does serve to highlight differences attributable to ␣ subunits. We find that at short time points, both ␣ IIb ␤ 3 and ␣ v ␤ 3 respond equivalently to RGD peptide with maximal ␤ 3 phosphorylation occurring at 2.0 mM peptide. However, time course studies reveal significant ␣ chain regulation of phosphorylation. A 1-h time point illustrates why phosphorylation in ␣ IIb ␤ 3 went undetected in earlier experiments. ␤ 3 phosphorylation in ␣ IIb ␤ 3 occurs rapidly and decays even in the presence of ligand, whereas phosphorylation in ␣ v ␤ 3 is maintained until the ligand has been removed. Although the physiologic relevance of this difference remains unknown, it may reflect the different fates of these two ␤ 3 integrins in active adhesive processes. ␣ IIb ␤ 3 -Mediated platelet adhesion is largely irreversible, whereas ␣ v ␤ 3 -mediated leukocyte adhesions turn over for efficient migration. Teleology notwithstanding, the ␣ subunit clearly regulates ␤ 3 phosphorylation, which merits further investigation.
The degree of ␤ 3 phosphorylation that occurs at any one time in the adhesion process is unknown. Our stoichiometry experiments may overestimate ␤ 3 phosphorylation for ␣ v ␤ 3 because the cells are held in suspension with soluble ligand present for 20 min. In the absence of suitable immobilized substrate, cells are unable to form and strengthen cytoskeletal connections. Under these conditions, it is possible that ␤ 3 phosphorylation increases to supraphysiologic levels. However, it is also possible that phosphorylation of ␤ 3 is a priming mechanism that occurs naturally in preparation for cell contact with substrate. In both primary cells and our K562 cell model system we found that approximately half of the ␤ 3 in the cells was phosphorylated under these conditions. Importantly, phosphate was incorporated primarily at Tyr-747 in ␣ v ␤ 3 and only significantly at Tyr-759 in ␣ IIb ␤ 3 . Because this difference was observed within identical cell backgrounds, it also indicates ␣ subunit regulation of this biochemical modification.
Because the phosphorylation of ␤ 3 differs when partnered with ␣ v or ␣ IIb , we compared the requirement for Tyr-747 and Tyr-759 together and separately in adhesion mediated by ␣ IIb ␤ 3 or ␣ v ␤ 3. Unlike ␣ v ␤ 3 , we found a clear role for Tyr-759 in ␣ IIb ␤ 3 adhesion in a static assay of firm adhesion. Mutation of either cytoplasmic ␤ 3 tyrosine reduced the ability of ␣ IIb ␤ 3 to mediate protein kinase C-stimulated adhesion to fibrinogen. As previously shown for ␣ v ␤ 3 , simultaneous mutation of both tyrosines completely inhibited adhesion via ␣ IIb ␤ 3 . A codependence on both tyrosines for successful adhesion has also been demonstrated for ␣ v ␤ 3 in a sensitive measure of adhesion force (5) . Further, although phosphorylation dependence has not been determined, binding partners unique for each domain of ␤ 3 that contain an NXXY motif have been identified (9) . Together these data suggest that despite the majority of phosphate incorporation that occurs at Tyr-747, both tyrosines are active in assembling signaling or structural protein assemblies for adhesion, perhaps with Tyr-747 serving as the primary functional site.
